(KIN) - Earnings & Price History

KIN: - 7.2, $207.39M, -0.25 (-3.36%)

Sector: Healthcare - Industry: Biotechnology

Kindred Biosciences, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for pets. The companys product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. Its lead product candidates include Zimeta, a pyrazolone anti-inflammatory drug, for the treatment of fever in horses; and KIND-010 for management of weight loss in cats and feline epo for anemia in cats. The company's other small molecule product candidates consist of KIND-014 for treatment of equine gastric ulcer syndrome; and KIND-015 for the treatment of metabolic syndrome in horses. It is also developing biologics products, such as KIND-510, a feline erythropoeitin for treatment of anemia in cats; KIND-502 for the treatment of allergic and immune-mediated diseases; KIND-0888, an antibody that targets CD20; various antibodies that target

Past KIN reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2014-11-13AMCKindred Biosci-0.318.748.989.168.729.162.00%-4.59%-2.67%52.60K
2014-08-13AMCKindred Biosci-0.35-0.4215.1215.8215.6714.9615.67-0.95%▲-3.51%-4.42%56.90K
2014-05-12AMCKindred Biosci-0.18-0.3815.0316.6316.5214.816.54-0.66%-9.02%-9.62%204.70K
2014-03-06AMCKindred Biosci-0.19-0.424.5824.582322.224.99-6.43%6.87%170.30K

Login | Register
Wednesday Aug 15, 2018   EST
Enter a Ticker:

Economic Calendar

MBA Mortgage Applications 7:00 AM ET Retail Sales 8:30 AM ET Empire State Mfg Survey 8:30 AM ET Productivity and Costs 8:30 AM ET Industrial Production 9:15 AM ET Atlanta Fed Business Inflation Expectations 10:00 AM ET Business Inventories 10:00 AM ET Housing Market Index 10:00 AM ET EIA Petroleum Status Report 10:30 AM ET Treasury International Capital 4:00 PM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR


index chart
index color